BSECompany UpdateFundraise1 Oct 2026
Paisalo Digital Ltd
Outcome of FCCB Committee Meeting
Paisalo Digital Ltd has informed that the FCCB Committee of its Board of Directors has approved the allotment of 2,59,12,548 Equity Shares upon conversion of 14,000 Foreign Currency Convertible Bonds (FCCBs). The fully paid-up equity capital of the Company has increased from Rs. 91,41,49,114 to Rs. 94,00,61,662.
BSEAGM/EGM1 Oct 2026
Goyal Aluminiums Ltd
Scrutinizer''s Report and details regarding voting results of 10th AGM of Goyal Aluminiums Limited
Goyal Aluminiums Ltd has announced the voting results of its 10th AGM, with members approving the resolutions as set out in the notice. The company has also provided a scrutinizer's report on the remote e-voting and e-voting process.
BSEAGM/EGMResults1 Oct 2026
Genesys International Corporation Ltd
Genesys International Corporation Limited has informed the exchange regarding Scrutinizer''s Report and Voting Results of the 44th Annual General Meeting held on September 30, 2026
Genesys International Corporation Ltd has informed the exchange regarding Scrutinizer's Report and Voting Results of the 44th Annual General Meeting held on September 30, 2026.
BSECompany UpdateRegulatory1 Oct 2026
Swojas Foods Ltd
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018.
Swojas Foods Ltd has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of equity shares and substitution of depository names as registered owners.
BSEAGM/EGM1 Oct 2026
Bombay Potteries & Tiles Ltd
Scrutinizer Report on e-voting for the 92nd Annual General Meeting.
Bombay Potteries & Tiles Ltd has released a scrutinizer report on e-voting for the 92nd Annual General Meeting.
BSEAGM/EGM1 Oct 2026
Force Motors Ltd-$
EGM for "A" Equity Shareholders of Force Motors Limited
Force Motors Ltd has announced an Extraordinary General Meeting (EGM) for 'A' Equity Shareholders to consider the proposal of removal of restrictions of transferability and other incidental conditions of 27,600 'A' Equity Shares.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the cessation of a non-executive non-independent director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the appointment of a non-executive non-independent director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the cessation of a non-executive non-independent director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the cessation of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the cessation of a non-executive non-independent director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the cessation of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the cessation of a non-executive non-independent director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the cessation of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of a Non-Executive Non-Independent Director.